|
ovarian response |
8 |
|
antral follicle count |
7 |
|
in vitro fertilization |
7 |
|
apoptosis |
6 |
|
letrozole |
6 |
|
medical abortion |
6 |
|
misoprostol |
6 |
|
progesterone receptor |
6 |
|
anti‐mullerian hormone |
5 |
|
cancer |
5 |
|
embryo cryopreservation |
5 |
|
fertility preservation |
5 |
|
gonadotrophin dosing |
5 |
|
in vitro fertilsation |
5 |
|
oocyte cryopreservation |
5 |
|
pain relief |
5 |
|
sperm cryopreservation |
5 |
|
threatened miscarriage |
5 |
|
abortifacient agents, nonsteroidal - pharmacokinetics |
4 |
|
abortion, induced - methods |
4 |
|
acetic acid |
4 |
|
acetic acid - pharmacokinetics |
4 |
|
dydrogesterone |
4 |
|
first trimester |
4 |
|
frozen embryo transfer |
4 |
|
hyaluronic acid |
4 |
|
hydrogen-ion concentration |
4 |
|
intrauterine lidocaine |
4 |
|
lidocaine gel |
4 |
|
live birth rate |
4 |
|
miscarriage |
4 |
|
misoprostol - pharmacokinetics |
4 |
|
normal saline |
4 |
|
oral progestogen |
4 |
|
pharmacokinetics |
4 |
|
progestogen |
4 |
|
randomized controlled trial |
4 |
|
saline contrast sonohysterography |
4 |
|
saline infusion sonogram |
4 |
|
transfer medium |
4 |
|
vaginal bleeding |
4 |
|
vaginal misoprostol |
4 |
|
anti-mullerian hormone |
3 |
|
conscious sedation |
3 |
|
cumulative live birth rate |
3 |
|
dehydroepiandrosterone |
3 |
|
follicle-stimulating hormone |
3 |
|
herlyn-werner-wunderlich syndrome |
3 |
|
obstructed hemivagina |
3 |
|
premature ovarian insufficiency |
3 |
|
renal agenesis |
3 |
|
septate uterus |
3 |
|
testosterone |
3 |
|
transcutaneous electrical nerve stimulation |
3 |
|
transvaginal oocyte retrieval |
3 |
|
adult |
2 |
|
antifungal therapy |
2 |
|
blood culture |
2 |
|
candida glabrata |
2 |
|
candidemia |
2 |
|
endometrial vascularity |
2 |
|
group b streptococcus |
2 |
|
ovarian osteoma |
2 |
|
ovarian teratoma |
2 |
|
patient preference |
2 |
|
pelvic ultrasonography |
2 |
|
pregnancy-induced hypertension |
2 |
|
screening |
2 |
|
small-for-gestational age |
2 |
|
subendometrial vascularity |
2 |
|
three-dimensional ultrasound |
2 |
